Publications Office of the EU
E-Valencia: vaccines - EU tenders
DisplayCustomHeader
Procurement Detail Actions Portlet
OP Portal - Procurement - Details

This page contains content generated automatically to improve findability and accessibility

- indicates text translated automatically in your browsing language

E-Valencia: vaccines

  • Published
    03/05/2011
  • Deadline
    08/06/2011
  • Opening of tenders
    20/06/2011
  • Awarded
    18/07/2011
  • Today
    10/06/2026
Status
Awarded
Type of contract
Supplies
Subject for Renewal
No
Buyer
Not available
Place of performance
NUTS code: Not available
Location of buyer
NUTS code: Not available
Business sector (Main CPV)
33651600 Vaccines
Total estimated contract value (excluding VAT)
4,900,000.00 EUR
Total final contract value (excluding VAT)
4,900,000.00 EUR
Tender reference number
236/11
Description

Procurement of vaccines against human papillomavirus (HPV).

Submission Method
Not available
Tenders may be submitted
Not defined
Information about a public contract, a framework agreement or a dynamic purchasing system (DPS)
The notice involves a public contract
Conditions for opening tenders (date)
20/06/2011 12:30
Place of performance
Not available
Award method
The most economic tender
Estimated value
4,900,000.00 EUR
Final contracted value
4,900,000.00 EUR
Award of contract
Official name: Glaxosmithkline SA
Postal address:
Town:
Postal code:
Country:
Prior information
Contract
Award
Footnote - legal notice

This content published on this page is meant purely as an additional service and has no legal effect. The Union's institutions do not assume any liability for its contents. The official versions of the relevant tendering notices are those published in the Supplement of Official Journal of the European Union and available in TED. Those official texts are directly accessible through the links embedded in this page. For more information please see Public Procurement Explainability and Liability notice.